Ten‐year outcomes of the first ‘one‐stop haematuria clinic’ in an Australian public hospital

Reynolds, B.; McCombie, Steve P; Botha, Erica; Hawks, Cynthia; Brown, Matthew; Hayne, Dickon

doi:10.1111/ans.16439

Cited by 4 publications

(13 citation statements)

References 22 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…For the 42 studies , quality was 'good' in eight [20,21,[24][25][26]36,53,57], 'fair' in 22 [23,27,29,[31][32][33]37,38,40,41,43,47,49,51,52,[54][55][56][58][59][60][61] and 'poor' in 12 studies [22,28,30,34,35,39,42,[44][45][46]48,50]. As studies rated of 'good' quality were deemed to have low bias, we wanted to investigate the prostate cancer prevalence specifically for these studies [20,21,[24][25][26]36,53,57].…”

Section: Study Qualitymentioning

confidence: 99%

Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis

et al. 2023

View full text Add to dashboard Cite

To investigate the prevalence of prostate cancer in men attending evaluation for haematuria, as this could help healthcare providers to determine whether men with haematuria should have prostate examinations performed. MethodsThe study was performed according to a pre-specified protocol uploaded to the International Prospective Register of Systematic Reviews (PROSPERO; CRD42022299383). A systematic search of MEDLINE, Ovid and Google Scholar was performed in December 2021. Two independent researchers evaluated all titles, available abstracts, and full texts. We included studies on adult men (aged ≥18 years) describing haematuria and prostate cancer. ResultsWe screened 4252 titles and abstracts when available and assessed 350 studies in full text. In total, 65 studies were included and 42 was summarised in a meta-analysis. In total, 18 752 men with haematuria were included, and the pooled prevalence (95% confidence interval [CI]) of prostate cancer was 3.0% (2.0-4.1%). In men with macroscopic haematuria, the pooled prevalence (95% CI) of prostate cancer was 5.9% (2.9-9.9%; n = 265/5373). In men with microscopic haematuria, the pooled prevalence (95% CI) of prostate cancer was 1.4% (0.8-2.2%; n = 71/6642). ConclusionOur findings indicate that the prevalence of prostate cancer is considerable in men attending evaluation for haematuria. Therefore, digital rectal examination and prostate-specific antigen measurement should become a standard procedure for all men with haematuria, especially for men with macroscopic haematuria.

show abstract

Section: Study Qualitymentioning

confidence: 99%

Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis

et al. 2023

View full text Add to dashboard Cite

show abstract

“…Refer patients aged 45 and over with unexplained visible haematuria or persistent visible haematuria following successful treatment of UTI, using a suspected cancer pathway. Prospective cohort studies of protocol driven haematuria clinics in secondary care show that 14-34% of outpatients presenting with visible haematuria are found to have malignant pathology (including non-urological cancers, eg, vulval and cervical cancer) 9101112. Other indications for referral are summarised in table 1.…”

Section: What You Should Domentioning

confidence: 99%

Visible haematuria

Madaan

Gandhi

Madaan

2022

BMJ

View full text Add to dashboard Cite

show abstract

“…[6][7][8][9][10][11][12][13][14][15][16] Onestop urological cancer pathways have been usual practice at our institution since 2008 with the introduction of the One Stop Haematuria Clinic. 17,18 The OSPC was established in 2011 initially to address health inequities and access barriers rural and remote men experience, 19 but later expanded to include all referrals to our service. 20,21 The purpose of the OSPC was to provide a streamlined assessment and diagnostic service for investigation of prostate cancer for rural men of Western Australia (WA).…”

Section: Introductionmentioning

confidence: 99%

Analysis of the financial impact and efficiency of the One Stop Prostate Clinic: A same day prostate cancer diagnostic clinic in the Australian public health system

Hawks

Al-Zubaidi

Viswambaram

et al. 2023

Journal of Public Health Research

Self Cite

View full text Add to dashboard Cite

Background: Access to prostate cancer diagnostic clinics are challenging for rural men in Western Australia due to remoteness and long travel distances. The One Stop Prostate Clinic (OSPC) provided same day assessment and diagnosis for prostate cancer in a public tertiary hospital to reduce access barriers for rural men. The objective of this study was to determine the financial and resource utilisation impact of the OSPC compared to a usual care pathway (UCP). Design and methods: Study design: Cost minimisation analysis of the OSPC model (assuming 100% new referrals) compared with a UCP, including impact on the Patient Assisted Transport Scheme (PATS) for rural men. An estimate of total cost comparison of OSPC and UCP pathways of outpatient and diagnostic costs was calculated based on journey mapping of attendance and follow up. Methods: Prospective data collection between August 2011 and November 2017 of referral, attendance and follow up outcomes. Journey mapping to identify time from referral to diagnosis, number of outpatient appointment (OPA) and travel savings. Results: A total of 1000 men attended – 466 (47%) rural and 534 (53%) metro. Mean time from referral to diagnosis was 57 days (rural) versus 63 (metro; p = 0.034)). The OSPC saved 543 travel episodes (distance of 1.5M km) and 658 OPA’s. Total episode of care costs for the OSPC (100% new) pathway estimated as $2237.34, compared to $2847.00 for a UCP, generating savings of $609.66 per attendance ($609,658.22 overall). Conclusion: The OSPC was more cost effective and efficient in comparison to a UCP.

show abstract

Ten‐year outcomes of the first ‘one‐stop haematuria clinic’ in an Australian public hospital

Cited by 4 publications

References 22 publications

Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis

Prevalence of prostate cancer in men with haematuria: a systematic review and meta‐analysis

Visible haematuria

Analysis of the financial impact and efficiency of the One Stop Prostate Clinic: A same day prostate cancer diagnostic clinic in the Australian public health system

Contact Info

Product

Resources

About